Inability to swallow oral medications
Inability to swallow oral medications
Inability to take oral medications
Inability to swallow medications
Inability to tolerate oral medications.
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements, or gastrointestinal (GI) procedure that could interfere with the oral absorption or tolerance of treatment.
Inability to take oral medications
Patients must not have significantly diseased or obstructed gastrointestinal tract, malabsorption, uncontrolled vomiting or diarrhea, or inability to swallow oral medications.
Inability to swallow or absorb drug
Inability to swallow oral medications.
Inability to swallow medications
Inability to swallow oral medications
Inability or unwillingness to swallow oral medications
Significantly diseased or obstructed gastrointestinal tract, malabsorption, uncontrolled vomiting or diarrhea or inability to swallow oral medications
Inability to swallow or tolerate oral medication.
Inability to swallow oral medications
Inability to swallow food or any condition of the upper gastrointestinal tract that precludes administration of oral medications
inability to take oral medication
inability to take oral medication;
Inability to tolerate oral medication
Inability or unwilling to swallow study drug
Inability to swallow medication
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements, or gastrointestinal (GI) procedure that could interfere with the oral absorption or tolerance of treatment
Inability to swallow medications
Inability to swallow food or any condition of the upper gastrointestinal tract that precludes administration of oral medications
Any gastrointestinal tract disease or other medical condition resulting in the inability to take oral medications
Inability to swallow intact tablets or inability to take pembrolizumab or cabozantinib
Inability to swallow medication
Inability to take oral medications on a continuous basis
Inability to take medications by mouth
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements, or gastrointestinal (GI) procedure that could interfere with the oral absorption or tolerance of treatment.
Inability to swallow oral medication
Inability to swallow oral medication or inability or unwillingness to comply with the administration requirements related to alisertib
Inability to swallow pills or any significant gastrointestinal disease which would preclude the adequate oral absorption of medications
Inability to take oral medication
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements or GI procedure that could interfere with the oral absorption or tolerance of treatment
Inability to swallow oral medication or inability or unwillingness to comply with the administration requirements related to alisertib
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements, or gastrointestinal (GI) procedure that could interfere with the oral absorption or tolerance of treatment.
Inability to take oral medications
Inability to swallow pills or any significant gastrointestinal diseases, which would preclude adequate absorption of oral medications.
PART B: Patients with inability to take oral medications, or, in the investigatorâ€™s opinion, gastrointestinal conditions or abnormalities likely to influence the absorption of oral medications
Inability to swallow oral medications or any malabsorption condition
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements, or gastrointestinal (GI) procedure that could interfere with the oral absorption or tolerance of treatment
Inability to swallow or absorb drug
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements, or gastrointestinal (GI) procedure that could interfere with the oral absorption or tolerance of treatment
Inability to swallow oral medication, inability or unwillingness to comply with the drug administration requirements, or gastrointestinal condition that could interfere with the oral absorption or tolerance of treatment.
Significant malabsorption syndrome or inability to tolerate oral medications
Inability to swallow oral medications
Inability to take oral medication
Inability to swallow pills or any significant gastrointestinal disease which would preclude the adequate oral absorption of medications
Clinical conditions affecting the intake and use of oral medications (e.g., inability to swallow, chronic diarrhea, and intestinal obstruction)
Inability to tolerate oral medications.
Inability to swallow oral medication or inability or unwillingness to comply with the administration requirements related to alisertib
Has inability to swallow oral medications or presence of a gastrointestinal disorder (e.g. malabsorption) deemed to jeopardize intestinal absorption of MK-8628
Inability to swallow oral medications or any medical conditions that may affect intestinal absorption of the study agent or inability to comply with oral medication
Inability to take oral medications, due to impaired swallowing ability or poor absorption capacity
Inability to swallow oral study treatment or any gastrointestinal disease or condition that would preclude adequate absorption of study treatment
Patients with significantly diseased or obstructed gastrointestinal tract, malabsorption, uncontrolled vomiting or diarrhea or inability to swallow oral medications
Inability to swallow oral medications
Inability to take oral medications
Inability to swallow food or any condition of the upper GI tract that precludes administration of oral medications.
Inability to swallow oral medication or condition that could interfere with oral absorption or tolerance of treatment
Inability to swallow oral medications
Inability to swallow or absorb drug
Inability to swallow oral medications (unless patients use a feeding tube in which case they are eligible)
Patients with significantly diseased or obstructed gastrointestinal tract, malabsorption, uncontrolled vomiting or diarrhea or inability to swallow oral medications
Inability to cooperate with NIPPV
Inability to swallow study medication
Inability to swallow oral medications
Inability to take medications by mouth
Have a known history of inability to absorb an oral agent
Participants with known inability to adequately absorb oral medication
Have a known history of inability to absorb an oral agent
